216 related articles for article (PubMed ID: 7002342)
1. Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.
Glazer RI
Cancer Chemother Pharmacol; 1980; 4(4):227-35. PubMed ID: 7002342
[No Abstract] [Full Text] [Related]
2. Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
Tanaka H; Kawakami T; Yang ZB; Komiyama K; Omura S
J Antibiot (Tokyo); 1989 Nov; 42(11):1722-4. PubMed ID: 2584153
[No Abstract] [Full Text] [Related]
3. Inhibitors of adenosine deaminase.
Agarwal RP
Pharmacol Ther; 1982; 17(3):399-429. PubMed ID: 6187032
[No Abstract] [Full Text] [Related]
4. Inhibitors of adenosine deaminase and the development of antiviral agents.
Cohen SS
Ann N Y Acad Sci; 1985; 451():204-14. PubMed ID: 2416257
[No Abstract] [Full Text] [Related]
5. Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johns DG; Adamson RH
Biochem Pharmacol; 1976 Jun; 25(12):1441-4. PubMed ID: 1084747
[No Abstract] [Full Text] [Related]
6. Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase.
Baker DC; Hanvey JC; Hawkins LD; Murphy J
Biochem Pharmacol; 1981 May; 30(10):1159-61. PubMed ID: 7259798
[No Abstract] [Full Text] [Related]
7. Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Adamson RH; Zaharevitz DW; Johns DG
Pharmacology; 1977; 15(1):84-9. PubMed ID: 840892
[TBL] [Abstract][Full Text] [Related]
8. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE
Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355
[No Abstract] [Full Text] [Related]
9. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
Lapi L; Cohen SS
Biochem Pharmacol; 1977 Jan; 26(1):71-6. PubMed ID: 299815
[No Abstract] [Full Text] [Related]
10. Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.
Agarwal RP; Spector T; Parks RE
Biochem Pharmacol; 1977 Mar; 26(5):359-67. PubMed ID: 849330
[No Abstract] [Full Text] [Related]
11. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA.
Lupidi G; Cristalli G; Marmocchi F; Riva F; Grifantini M
J Enzyme Inhib; 1985; 1(1):67-75. PubMed ID: 3916912
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenosine deaminase and of platelet aggregation by 2-azidoadenosine, a photolysable analogue of adenosine.
Cusack NJ; Born GV
Proc R Soc Lond B Biol Sci; 1976 May; 193(1112):307-11. PubMed ID: 6968
[No Abstract] [Full Text] [Related]
13. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
[No Abstract] [Full Text] [Related]
14. Effect of an adenosine deaminase inhibitor on survival of mouse pancreatic islet allografts.
Lum CT; Sutherland DE; Eckhardt J; Matas AJ; Najarian JS
Transplantation; 1979 May; 27(5):355-7. PubMed ID: 107635
[No Abstract] [Full Text] [Related]
15. Adenosine deaminase inhibitors: differential effects on multiple forms of adenosine deaminase.
Constine J; Glazer RI; Johns DG
Biochem Biophys Res Commun; 1978 Nov; 85(1):198-202. PubMed ID: 570397
[No Abstract] [Full Text] [Related]
16. Mechanism of ATP catabolism induced by deoxyadenosine and other nucleosides in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Adv Exp Med Biol; 1989; 253B():267-74. PubMed ID: 2558538
[No Abstract] [Full Text] [Related]
17. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
Carson DA; Wasson DB; Lakow E; Kamatani N
Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
20. Quantum chemical study of the electronic and conformational characteristics of adenosine and 8-substituted derivatives: functional implications in the mechanism of reaction of adenosine deaminase.
Orozco M; Lluis C; Mallol J; Canela EI; Franco R
J Pharm Sci; 1990 Feb; 79(2):133-7. PubMed ID: 2324961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
